pharma · Urea cycle disorders (UCD) · Cannabis Smoking · CAMP
Camp4 Therapeutics
Camp4 Therapeutics Corp
Camp4 Therapeutics trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
Cambridge, USA HQ
2016 Founded
60 Employees
Public company Type
CAMP · NYSE Ticker
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2016
- Employees
- 60
- Programs
- 9
- Drugs
- 15
- Patents
- 4
Camp4 Therapeutics clinical trials
Registry index of 9 ClinicalTrials.gov studies linked to Camp4 Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Camp4 Therapeutics trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Camp4 Therapeutics.
-
CPS-101 — Phase 1
Clinical update -
Ketamine Hydrochloride — Phase 3
Clinical update -
Conventional sound generator (SG) — Phase 3
Clinical update -
Active smoked cannabis — Phase 2
Clinical update -
Virtual Reality Exposure Therapy - Dynamic — Phase 3
Clinical update -
Treatment as Usual — Phase 2
Clinical update -
Placebo — Phase 3
Clinical update -
IncobotulinumtoxinA (XEOMIN®) — Phase 3
Clinical update